Bluejay Diagnostics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bluejay Diagnostics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2020 to Q2 2024.
  • Bluejay Diagnostics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.48M, a 12% increase year-over-year.
  • Bluejay Diagnostics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$9.4M, a 12.1% increase year-over-year.
  • Bluejay Diagnostics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$9.95M, a 7.07% decline from 2022.
  • Bluejay Diagnostics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$9.3M, a 167% decline from 2021.
  • Bluejay Diagnostics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$3.49M, a 201% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$9.4M -$2.48M +$338K +12% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$9.74M -$2.33M +$211K +8.32% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-14
Q4 2023 -$9.95M -$2.3M +$83.5K +3.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$10M -$2.3M +$662K +22.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$10.7M -$2.81M -$876K -45.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$9.82M -$2.54M -$526K -26.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-14
Q4 2022 -$9.3M -$2.39M +$355K +12.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$9.65M -$2.96M -$1.77M -148% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$7.89M -$1.94M -$2.58M -403% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$5.31M -$2.01M -$1.82M -937% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$3.49M -$2.74M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 -$1.19M -$1.07M -832% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $640K Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 -$194K Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q3 2020 -$128K Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.